The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad.
In his virtual address at the 25th meeting of the Group of Ministers, the Health Minister said, “180 districts have showed no fresh cases in the last seven days, 18 districts in 14 days, 54 districts in 21 days and 32 districts were bereft of any fresh cases in the last 28 days.” He said that across the country, the number of patients in ICU beds is 4,88,861 while 1,70,841 patients were on ventilators and 9,02,291 patients were on oxygen support.
Updated:
The major news headlines of the day, and more.
Share Article
AAA
An oxygen tanker arrives at Delhi’s Batra hospital on May 1, 2021. As many as 12 COVID-19 patients died in the hospital earlier in the day due to lack of oxygen.
| Photo Credit:
V.V. Krishnan
The major news headlines of the day, and more. With the death of the 12 patients in the south Delhi hospital which announced at 12.30 p.m. that it had run out of oxygen the number of hospital patients who have lost their lives in the deepening crisis in the last eight days has gone up to 57.
Updated:
The major news headlines of the day, and more.
Share Article
AAA
Syringes filled with Covishield lie on an ice box at a primary health centre in Srinagar on April 28, 2021. | Photo Credit:
AP
The major news headlines of the day, and more.
“As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs 400 to Rs 300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives,” Serum Institute CEO Adar Poonawalla tweeted.
As the registration of all citizens above 18 years of age for vaccination against COVID-19 started on the CoWIN portal at 4 p.m. on April 28, many people took to social media to complain about the technical problems they faced trying to register themselves for the third phase of the inoculation drive that is scheduled to begin from May 1.
Updated:
60 million doses of AstraZeneca’s vaccine are to be shared globally
Share Article
AAA
Vital supply: The White House said 10 million doses could be cleared for export “in coming weeks” and the rest by June.
60 million doses of AstraZeneca’s vaccine are to be shared globally
India expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources told Reuters, as New Delhi battles a devastating surge in infections.
On Monday, the White House said 10 million doses could be cleared for export “in coming weeks” and the rest by June. It has not revealed potential beneficiaries, but the sources said India could gain the most.